Brief: UNITY Biotechnology Reports Q3 2022 Results
08/11/2022 22:45
Nov 8 (Reuters) - UNITY Biotechnology Inc UBX.O :
* UNITY BIOTECHNOLOGY, INC. REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS UPDATES
* UNITY BIOTECHNOLOGY INC - QTRLY NET LOSS PER SHARE $1.36
Source text for Eikon: ID:nGNX3hcgSY
Further company coverage: UBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force